NBNovaBridge Hub

Public methodology

Methodology

Our analysis combines editorial criteria, commercial transparency and continuous revision. We do not accept payment for scores or verdicts.

1. Screening

We select relevant offers and verify who sells them, how they charge and what information is publicly available.

2. Evidence

We compare claims, composition or features against public sources, manufacturer disclosures and reasonable limits.

3. Experience

We assess clarity, checkout access, support responsiveness, refund window and potential additional costs.

4. Verdict

We publish benefits, limitations, the right user profile and the commercial disclosure - explicitly, on every review.

5. Keeping reviews current

Prices, guarantees and offer details can change on the manufacturer's side without notice. We periodically revisit reviews, but the official page always overrides anything stated here.

6. How we score

Every reviewed product receives a 0-10 editorial score built from five weighted criteria. The score reflects disclosure quality and buying conditions - not clinical effectiveness, which we are not positioned to test or verify.

Hard-cap policy: when a product's core sales claim is factually false or contradicts basic, settled science (for example, a claimed disease cure, a claim to predict independent random events, or a fabricated scientific mechanism), we do not let the weighted average absorb that failure - we cap the score directly and, in the most serious cases, remove the product from the catalog rather than publish a middling grade. A weighted average alone can't fail a product hard enough for that kind of claim, so we don't rely on it alone.